Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 19, No. 4, 2005   

Free Abstract     Article (Fulltext)     Article (PDF 119 KB)     

Original Paper

Bendrofluazide Fails to Reduce Elevated Blood Pressure Levels in the Immediate Post-Stroke Period
Penelope J. Eamesa, Thompson G. Robinsona, Ronney B. Paneraib, John F. Pottera

aUniversity of Leicester, Department of Cardiovascular Sciences, Ageing and Stroke Medicine Group, The Glenfield Hospital, Leicester, and
bDivision of Medical Physics, University of Leicester, Leicester Royal Infirmary, Leicester, UK

Address of Corresponding Author

Cerebrovasc Dis 2005;19:253-259 (DOI: 10.1159/000084089)


 goto top of page Key Words

  • Stroke
  • Cerebral autoregulation
  • Bendrofluazide
  • Blood pressure

 goto top of page Abstract

Introduction: Blood pressure (BP) levels, beat-to-beat blood pressure variability, dynamic cerebral autoregulation and cardiac baroreceptor sensitivity are frequently abnormal following acute stroke and are associated with an adverse short- and long-term prognosis. Thiazide diuretics are effective antihypertensive agents in preventing primary and secondary stroke, but their hypotensive and cerebral autoregulatory effects in the immediate post-stroke period have not been studied. Methods: Thirty-seven hypertensive neuroradiologically proven ischaemic stroke patients were randomized in a double-blind, placebo controlled, parallel group study to bendrofluazide 2.5 mg daily or matching placebo, within 96 h of stroke onset, for a 7-day period. Casual and non-invasive beat-to-beat arterial BP levels, cerebral blood flow velocity, ECG and transcutaneous carbon dioxide levels were measured within 70 ± 20 h of cerebral infarction and again 7 days later. Dynamic cerebral autoregulatory indices, pulse interval, BP variability and cardiac baroreceptor sensitivity were also calculated. Results: Small, non-significant falls were seen in casual and beat-to-beat BP levels over the 7-day period in both active and placebo-treated patients with no differences between treatments. No significant changes were seen in dynamic cerebral autoregulation or in cardiac baroreceptor sensitivity during the follow-up in either group. Conclusion: Following acute ischaemic stroke, the standard dose of bendrofluazide at 2.5 mg daily in this study sample did not lower systemic BP levels over the subsequent 7-day period. There was no evidence that bendrofluazide significantly altered cerebral autoregulation or improved cardiac baroreceptor sensitivity post-ictus. Bendrofluazide appears to be an ineffective hypotensive agent at the standard dosage in the initial post-stroke period.

Copyright © 2005 S. Karger AG, Basel


 goto top of page Author Contacts

Prof. J.F. Potter
University of Leicester, Department of Cardiovascular Sciences
Ageing and Stroke Medicine Group, The Glenfield Hospital
Leicester, LE3 9QP (UK)
Tel. +44 116 2563643, Fax +44 116 2322976, E-Mail penny.eames@UHL-tr.nhs.uk


 goto top of page Article Information

Received: April 26, 2004
Accepted: November 3, 2004
Published online: February 22, 2005
Number of Print Pages : 7
Number of Figures : 0, Number of Tables : 4, Number of References : 26

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 15731556)
Download Citation
Cited In



This journal is part of the first subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues

Case Reports in Neurology


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.




copyright  © 2009 S. Karger AG, Basel